Back to GLENVIEW CAPITAL MANAGEMENT, LLC

MYGN
Showing 8 of 27 quarters

Position history for GLENVIEW CAPITAL MANAGEMENT, LLC's holdings in MYRIAD GENETICS INC

GLENVIEW CAPITAL MANAGEMENT, LLC holds 5.4M shares of MYGN (MYRIAD GENETICS INC), worth $24.4M as of 2026-Q1. The position was increased (+18.0% shares). MYGN represents 0.6% of GLENVIEW CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$24.4M

Current Shares

5.4M

Total Value Change

-$67.3M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
5.4M
+18.0%
$24.4M0.6%$5.29
48
2025-Q4
Unchanged
4.6M
0.0%
$28.2M0.6%$6.17
0
2025-Q3
Unchanged
4.6M
0.0%
$33.2M0.7%$7.24
0
2025-Q2
Increased
4.6M
+17.6%
$24.4M0.7%$5.25
48
2025-Q1
Decreased
3.9M
-6.2%
$34.6M0.9%$8.88
0
2024-Q4
Increased
4.2M
+229.6%
$57M1.4%$13.63
76
2024-Q3
Decreased
1.3M
-66.3%
$34.6M0.7%$26.46
0
2024-Q2
Decreased
3.7M
-24.2%
$91.7M1.8%$24.46
0

Other major holders of MYGN: BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used